companydata.dkcompanydata.dk

Ranger Biotechnologies A/S: Financial statements 2021

CVR: 32280404

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

Ranger Biotechnologies A/S (CVR 32280404) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 5,708,942 and a net result of DKK 171,975 compared with DKK 0 the year before. That is an increase of 135% compared with the year before. Equity in the 2021 report amounted to DKK 889,341. The solvency ratio was 15.7%. The company had 9 employees in the financial year.

Gross Profit
DKK 5,708,942
Profit/Loss
DKK 171,975
Equity
DKK 889,341
Total Assets
DKK 5,667,922
Employees
9

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-5.7M172K889K9
2020-2.4M0717K3
2019-591K-12.7M717K2
2018--832K-975K13.4M1
2017--1.3M-4.9M14.3M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Ranger Biotechnologies A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Ranger Biotechnologies A/S: The 2020 annual report is outJun 14, 2021

Ranger Biotechnologies A/S has published its annual report for 2020. Gross profit came to DKK 2,429,278, and the net result was DKK 0.

About Ranger Biotechnologies A/S

Ranger Biotechnologies A/S is a Danish company of the type Aktieselskab based in Odense SØ, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MIRRX THERAPEUTICS A/S and MIRX THERAPEUTICS A/S. The management consists of Hans Thorleif Møller. The board consists of Christina Møller Udesen (chair), Hans Thorleif Møller, Kasper Tvede Larsen and Søren Tvede Larsen. The company is owned by QUERDENKER ApS and Outlate Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -409,444 and a net result of DKK -843,419 compared with DKK -1,138,092 the year before. Equity in the 2025 report amounted to DKK 711,273.

Source: annual report 2025, Danish Business Authority